Mark Ruscin, PharmD  

Mark Ruscin, PharmD
Department of Internal Medicine
Division of General Internal Medicine
Professor, Department of Pharmacy Practice, SIU-E School of Pharmacy
Adjunct Assistant Professor, Department of Internal Medicine, SIU School of Medicine

Office Location: 701 N. 1st Street
Springfield, Illinois 62702
Telephone: 217-545-3934


Degree Year Institution Area
Doctor of Pharmacy 1993 University of Illinois Chicago Pharmacy Practice
Pharmacy Residency 1994 University of Illinois Chicago Pharmacy Practice
Pharmacy Fellowship 1995 University of Rhode Island Geriatrics
 
Board Certifications
Board Certified Pharmacotherapy Specialist (BCPS)
 
Academic Interests

nutrition issues in aging, pharmacoepidemiology, drug safety
 
Clinical Interests

Geriatric Pharmacology and Medicine
 
Representative Publications
  1. Page RL, Ruscin JM, Bainbridge JL, Brieke AA. Restless legs syndrome induced by escitalopram: case discussion and literature review. Pharmacotherapy 2008;28:271-280.
  2. Linnebur SA, Vondracek SF, VandeGriend JP, Ruscin JM, McDermott MT. Prevalence of vitamin D insufficiency in elderly ambulatory outpatients in Denver, Colorado. Am J Geriatr Pharmacother 2007;5:1-8.
  3. Ruscin JM, Page RL. Probable thiazide diuretic-induced angioedema in a sulfonamide antibiotic allergic patient. Am J Geriatr Pharmacother 2006;4:325-329.
  4. Page RL, Ruscin JM. The risk of adverse drug events and hospital-related morbidity and mortality among older adults with potentially inappropriate medication use. Am J Geriatr Pharmacother 2006;4:297-305.
  5. Hutt EA, Ruscin JM, Corbett K, Radcliff TA, Kramer AM, et al. A multifaceted intervention to implement guidelines improved treatment of nursing home-acquired pneumonia in a state veterans home. J Am Geriatr Soc 2006;54:1694-1700.
  6. Linnebur SA, Ruscin JM. Acetylcholinesterase inhibitor use in geriatric outpatients with dementia. Am J Health-Syst Pharm 2005;62:923-926
  7. Ruscin JM, Page RL, Yeager BF, Wallace JI. Tumor necrosis factor-alpha (TNF) and involuntary weight loss in elderly, community dwelling adults. Pharmacotherapy 2005;25:313-319
  8. Ruscin JM. Update on the role of anticholinergic drug therapy in the management of overactive bladder. Consult Pharm 2005;20:667-677
  9. Valuck RJ, Ruscin JM. A case-control study on adverse effects: H2 blocker or proton pump inhibitor use and risk of vitamin B12 deficiency in older adults. J Clin Epi 2004;57:422-428.
  10. Page RL, Gozansky W, Ruscin JM. Trogilitazone induced heart failure. Pharmacotherapy 2003;23:945-954.
  11. Ruscin JM, Page RL, Valuck RJ. Vitamin B12 Deficiency Associated with Histamine-2 Receptor Antagonists and a Proton Pump Inhibitor. Ann Pharmacother 2002;36:812-816.
  12. Ruscin JM, Page RL. Newer Pharmacological Agents and Their Relevance to Older Adults. Ann Long-Term Care 2001;9(10):43-55.
  13. Ruscin JM, Morgenstern NE. Tolterodine Use for Symptoms of Overactive Bladder. Ann Pharmacother 1999;33:1073-82.
  14. Ruscin JM, Astroth JD. Lingual Lesions Secondary to Prolonged Contact with Salsalate Tablets. Ann Pharmacother 1998;32:1248
  15. Ruscin JM, Semla TP. Assessment of Medication Management Skills in Older Outpatients. Ann Pharmacother 1996:30;1083-88
  16. Ruscin JM. Drug-Induced Disease and Functional Impairment in Older Adults. Pharmacy Times 1996;62:6-14HPT

BulletTop